Does CETUXIMAB Cause Salivary hypersecretion? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Salivary hypersecretion have been filed in association with CETUXIMAB (ERBITUX). This represents 0.1% of all adverse event reports for CETUXIMAB.
15
Reports of Salivary hypersecretion with CETUXIMAB
0.1%
of all CETUXIMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Salivary hypersecretion From CETUXIMAB?
Of the 15 reports, 7 (46.7%) required hospitalization, and 2 (13.3%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which CETUXIMAB Alternatives Have Lower Salivary hypersecretion Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL